Classement en actions
#19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Prix de l'action
$0.20876331
Capitalisation boursière
$1.38M
Changement (1 jour)
1.15%
Changement (1 an)
-64.84%
Échange IntegraGen SA (ALINT)
Marge opérationnelle de IntegraGen SA (ALINT)
Marge opérationnelle au July 2026 TTM : -56.21%
Selon les derniers rapports financiers et le cours de l'action de IntegraGen SA, la marge opérationnelle actuelle (TTM) est de -56.21%. À la fin de 2023, elle était de -1.47%.
Historique de la marge opérationnelle pour IntegraGen SA de 2008 à 2026
Marge opérationnelle à la fin de chaque année
| Année |
Marge opérationnelle |
Changez |
|
2026 (TTM) |
-56.21%
|
505.71%
|
|
2024 |
-9.28%
|
531.29%
|
|
2023 |
-1.47%
|
38.68%
|
|
2022 |
-1.06%
|
307.69%
|
|
2021 |
-0.26%
|
-90.81%
|
|
2020 |
-2.83%
|
-35.39%
|
|
2019 |
-4.38%
|
-74.19%
|
|
2018 |
-16.97%
|
-42.77%
|
|
2017 |
-29.65%
|
4.55%
|
|
2016 |
-28.36%
|
-29.05%
|
|
2015 |
-39.97%
|
45.29%
|
|
2014 |
-27.51%
|
-48.53%
|
|
2013 |
-53.45%
|
7.03%
|
|
2012 |
-49.94%
|
-3.33%
|
|
2011 |
-51.66%
|
-39.10%
|
|
2010 |
-84.83%
|
-15.87%
|
|
2009 |
-100.83%
|
-13.88%
|
|
2008 |
-117.08%
|
0.00%
|
Marge opérationnelle pour des entreprises similaires ou concurrentes
| Entreprise |
Marge opérationnelle |
Différence de Marge Opérationnelle |
Pays |
|
|
45.30% |
-100.81%
|
DK
|
|
|
38.97% |
-100.69%
|
US
|
|
|
24.32% |
-100.43%
|
US
|
|
|
25.32% |
-100.45%
|
BE
|
|
|
25.64% |
-100.46%
|
NL
|
Qu'est-ce que la Marge opérationnelle d'une entreprise ?
La Marge opérationnelle est un indicateur clé pour évaluer la rentabilité d'une entreprise. Une marge d'exploitation plus élevée est généralement préférable car elle montre qu'une entreprise peut vendre ses produits ou services bien au-dessus de leurs coûts de production. Elle se calcule en divisant les bénéfices par le chiffre d'affaires.